期刊文献+

冠心病患者胸腺苷合成酶多态性的探讨

Polymorphisms of thymidylate synthase in patients with coronary heart disease
下载PDF
导出
摘要 目的研究胸腺苷合成酶(TS)5’-非翻译区(UTR)28bp串联重复序列多态性、3-’UTR1494bp位6bp插入或缺失多态性与血浆同型半胱氨酸(Hcy)水平及冠心病之间的关系。方法用多聚酶链式反应(PCR)方法检测122例冠心病患者(冠状动脉造影显示至少有一支血管狭窄≥50%)与56例对照组(冠状动脉造影未发现任何可辨认斑块或狭窄)的TS 5-’UTR 28bp串联重复序列多态性;用聚合酶链反应-限制性片段多态性(PCR-RFLP)分析3-’UTR1494bp位6bp插入或缺失多态性;用荧光衍生后高压液相色谱分离法检测血浆总Hcy水平。结果(1)冠心病组的血浆Hcy水平(12.99±4.76)μmol/L高于对照组(10.95±4.75)μmol/L(P=0.009)。(2)TS5-’UTR 28bp串联重复序列有三种基因型(3R/3R,3R/2R,2R/2R),这三种基因型频率在冠心病组和对照组之间的分布有差异(P=0.029);TS28各基因型个体的Hcy水平在冠心病组高于对照组(P=0.03)。3R/3R、3R/2R基因型个体的Hcy水平均高于2R/2R型个体(分别为P<0.001和P=0.011),但3R/3R基因型个体与3R/2R基因型个体的Hcy水平间的差异没有统计学意义(P=0.979)。(3)TS3-’UTR6bp插入或缺失多态性有三种基因型(+6bp/+6bp,+6bp/-6bp,-6bp/-6bp),这三种基因型频率在冠心病组和对照组之间的分布差异无显著性(P>0.05)。TS6各基因型个体的Hcy水平在冠心病组高于对照组(P=0.006)。冠心病组TS6 bp各基因型个体间Hcy水平的的差异均没有统计学意义(P均>0.05)。结论(1)高Hcy血症与冠心病有关系。(2)TS基因5-’UTR28bp串联重复序列多态性可能是冠心病发病中的一个遗传因素。3 R与冠心病组个体的Hcy水平有关系。 Objective To study the relationship between polynaorphisa-n of 28bp tandena repeat sequence in 5'-UTR and 6- bp variation at bp1494 in the 3'-UTR of thymidylate synthase(TS), plasma homcysteine (Hey) levels and coronary heart disease. Methods All the subjects were underwent coronary angiography. Subjects ( n=121) with≥50% stenosis in at least one coronary vessels were defined as CHD. Subjects ( n = 56) without any stenosis in all coronary vessels were defined as controls. TS 28bp genotyping was analyzed using PCR and TS 6bp genotyping was performed using PCR-RFLP. Total plasma Hey levels were measured by HPLC with fluorescence detection. Results ( 1 ) Mean Hey concentration was significantly higher in ClAD patients ( 12.99 ± 4.76μmol/L) than that in controls( 10.95 ± 4.75μmol/L) ( P = 0. 009 ). (2) There was signlfieant difference in TS 28bp genotype frequencies between CHD group and controls respectively( P = 0.029), Hey levels of different T828 genetypes in the CHD group were higher than that in controls (P=0.03). In the CHD group, Hey levels of 3R/3R were higher than that of 2R/2R( P〈0. 001 ) and Hey levels of 3R/2R was higher than that of 2R/2R(P=0.011). There was no difference of the Hey levels between 3R/3R and 3R/2R( P =0.979). (3)No significant difference in TS 6bp genotype frequencies between the two groups was boserved ( P = 0. 285 ). Hey levels of different TS6 genetypes in the CHD group were higher than that in controls (P=0.006). In CHD group, there was no significant difference between the Hey levels in the individuals with the genetypes of + 6bp/+ 6bp, + 6bp/- 6bp, -6bp/-6bp. Conclusion (1 )Hyperhomocysteinenaia is associated with CHD. (2 ) Polymorphism of TS 5'-UTR 28 bp correlates with CHD and it may be a possibly genetics factor of CHD.
出处 《中国心血管杂志》 2005年第5期343-346,353,共5页 Chinese Journal of Cardiovascular Medicine
基金 福建省科技项目基金资助(编号:2001Z042)
关键词 冠心病 同型半胱氨酸 胸腺苷合成酶 基因 多态性 冠心病患者 酶多态性 合成酶 串联重复序列多态性 血浆同型半胱氨酸 Coronary heart disease(CHD) Homocysteine (Hcy) Thyrnidylate synthase ( TS) Gene Polymorphism
  • 相关文献

参考文献8

  • 1Bozkurt A, Toyaksi H, Acarturk E,et al. The effects of hyperhomocysteinemia on the presence, extent, and severity of coronary artery disease [ J ] . Jpn Heart J,2003,44: 357-368.
  • 2Nobuyuki H, Hideo A, Katsuhiko O, et al. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5' -terminal regulatory region of the human gene for thyrnidylate synthase [J]. Cell Structure and Function, 1995,20-191-197.
  • 3Cornelia MU, Jeannette Bigler, Christine M, et al.Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene [J].Cancer Epidemiology Biomarkers & Prevention, 2000,9:1381-1385.
  • 4Christine FS, Martyn TS, Alan H, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethltransferase genes and risk of adult acuate lymphocytic leukemia[J]. Blood, 2002,99:3786-3791.
  • 5Kazuyuki K, Kenjiomura, Eijikanehim, et al. Polymorphic tandem repeats in the thyrnidylate synthase gene is associated with its protein expression in human grastrointestinal cancers [J ]. Anticancer Research, 1999, 19:3249-3252.
  • 6Kazuyuki K, Dennis S, Ji MP, et al. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression[J]. Clinical Cancer Research, 2001, 7: 4096-4101.
  • 7Mandola, Michael V, Stoehlmacher, et al. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels [J ]. Pharmacogenetics. 2004,14.319-327.
  • 8J萨姆布鲁斯 D W 拉塞尔著 黄培堂 译.分子克隆实验指南(上册)[M](第3版)[M].北京:科学出版社,2002.605-606.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部